These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8801618)
1. Review of macronutrient substitutes by the Food and Drug Administration. Rulis AM Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S47-50. PubMed ID: 8801618 [No Abstract] [Full Text] [Related]
3. Focus on substitutes that alter gastrointestinal physiology. Glinsmann W Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S27-30; discussion S31-7. PubMed ID: 8801614 [No Abstract] [Full Text] [Related]
4. Food contact substances and the need for food safety reform. Heckman JH Regul Toxicol Pharmacol; 1996 Dec; 24(3):236-9. PubMed ID: 8975751 [No Abstract] [Full Text] [Related]
5. FDA clarifies policy on salmonellae in feed, holds workshop on anti-Salmonella additives. J Am Vet Med Assoc; 1994 Oct; 205(8):1088. PubMed ID: 7890561 [No Abstract] [Full Text] [Related]
6. Food safety: are our laws too lenient? Too strict? Hutt PB Am Med News; 1980 Mar; 23(11):suppl 3-4, 10. PubMed ID: 10246040 [No Abstract] [Full Text] [Related]
7. Regulatory constraints on agriculture. Kolbye AC Environ Qual Saf; 1975; 4():1-5. PubMed ID: 1193048 [No Abstract] [Full Text] [Related]
9. Technological aspects of use of sulfiting agents in food. Modderman JP J Assoc Off Anal Chem; 1986; 69(1):1-3. PubMed ID: 3949680 [TBL] [Abstract][Full Text] [Related]
10. Introduction: safety and regulatory issues related to the use of macronutrient substitutes in the food supply. Masten LW Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S3-5. PubMed ID: 8801615 [No Abstract] [Full Text] [Related]
11. Food ingredient review at FDA: recent data and initiatives to improve the process. Rulis AM; Tarantino LM Regul Toxicol Pharmacol; 1996 Dec; 24(3):224-31. PubMed ID: 8975749 [No Abstract] [Full Text] [Related]
12. From aspartame to Xenical. A look at the FDA review process. Trissler RJ J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675 [No Abstract] [Full Text] [Related]
13. Food industry initiatives to improve the FDA's food ingredient review processes. Pape SM Food Drug Law J; 1996; 51(3):413-21. PubMed ID: 11797718 [No Abstract] [Full Text] [Related]
14. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory? Silverglade BA Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324 [No Abstract] [Full Text] [Related]
15. The danger in food safety policies. Hall RH Can Med Assoc J; 1978 Jan; 118(1):83-7. PubMed ID: 620390 [No Abstract] [Full Text] [Related]
16. Panel discussion: what is the future of macronutrient substitutes in North America? Borzelleca JF; Cheney M; Davidson MH; Degnan FH; Derfler PS; Forbes AL; Glinsmann W; Heckman JH; Miller SA; Rulis AM; Masten LW Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S51-9. PubMed ID: 8801619 [No Abstract] [Full Text] [Related]
17. The FDA, medical foods, and patents. Czap A Altern Med Rev; 2002 Oct; 7(5):367-8. PubMed ID: 12410621 [No Abstract] [Full Text] [Related]
18. Regulatory aspects of the introduction of new macronutrient substitutes. Rulis AM; Pellicore LS; Thorsheim HR Ann N Y Acad Sci; 1997 May; 819():22-8. PubMed ID: 9186757 [No Abstract] [Full Text] [Related]
19. Origins and causes of the problem: the regulatory context. Merrill RA Regul Toxicol Pharmacol; 1996 Dec; 24(3):214-7. PubMed ID: 8975747 [No Abstract] [Full Text] [Related]
20. Improving exposure estimates for indirect food additives. Heimbach JT Drug Metab Rev; 1995; 27(4):563-72. PubMed ID: 8925717 [No Abstract] [Full Text] [Related] [Next] [New Search]